Ariad Pharma (ARIA) Misses Q1 Loss Views by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $24.07 --0%
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
CARE, MNSB, PHAR, More
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
CARE, MNSB, PHAR, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $81 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue shares jump on Q3 results and 2027 outlook
- Five Star Bancorp (FSBC) Tops Q3 EPS by 7c
- H2O America (HTO) Misses Q3 EPS by 16c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
